Ultragenyx Pharmaceutical (RARE) Operating Expenses (2013 - 2026)
Ultragenyx Pharmaceutical (RARE) reported Operating Expenses of $289 million for Q2 2026, up 5.1% from $275 million a year earlier but down 5.2% from the prior quarter.
Ultragenyx Pharmaceutical (RARE) Operating Expenses (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Ultragenyx Pharmaceutical's Operating Expenses came in at $1.25 billion, up 11.7% year-over-year; for FY2025, it came in at $1.21 billion, up 10.2% from FY2024.
- Operating Expenses has a five-year compound annual growth rate of 15.0% (FY2020 to FY2025).
- By year, Operating Expenses came in at $1.1 billion in FY2024 (+9.3%), $1 billion in FY2023 (-0.9%), $1.01 billion in FY2022 (+38.1%) and $733.14 million in FY2021 (+22.0%).
- Five-year quarterly Operating Expenses spans a low of $171.48 million in Q3 2021 and a high of $330.82 million in Q3 2025.
- Year over year, Operating Expenses has now increased in each of the last ten quarters, with growth averaging 10.1% over the last eight quarters.
- The high point for year-over-year Operating Expenses in five years was Q3 2022 (growth of 84.1%); the low point was Q3 2023 (a decline of 23.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $305 million (Q1 2026), $320.56 million (Q4 2025) and $330.82 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.12 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 10.56 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 12.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -6.09 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -9.70 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 6.54 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 18.20 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 6.68 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 2.09 Bn |
| 10 | Ultragenyx Pharmaceutical | 1.48 Bn | -321.29 Mn | 180.00 Mn | 289.00 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 289.00 Mn |
| Mar 31, 2026 | 305.00 Mn |
| Dec 31, 2025 | 320.56 Mn |
| Sep 30, 2025 | 330.82 Mn |
| Jun 30, 2025 | 275.00 Mn |
| Mar 31, 2025 | 282.00 Mn |
| Dec 31, 2024 | 286.95 Mn |
| Sep 30, 2024 | 271.48 Mn |
| Jun 30, 2024 | 263.39 Mn |
| Mar 31, 2024 | 274.18 Mn |
| Dec 31, 2023 | 248.98 Mn |
| Sep 30, 2023 | 243.15 Mn |
| Jun 30, 2023 | 256.27 Mn |
| Mar 31, 2023 | 254.60 Mn |
| Dec 31, 2022 | 248.98 Mn |
| Sep 30, 2022 | 315.77 Mn |
| Jun 30, 2022 | 230.94 Mn |
| Mar 31, 2022 | 216.57 Mn |
| Dec 31, 2021 | 185.95 Mn |
| Sep 30, 2021 | 171.48 Mn |
Ultragenyx Pharmaceutical Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-expenses&ticker=RARE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-expenses", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=operating-expenses&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();